JF
CMRA

Jump Financial’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Jump Financial’s Portfolio CMRA Stock Details CMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,922
Closed -$58K – 2093
2022
Q2 		$58K Buy
+21,922
New +$72.6K ﹤0.01% 1490

Other funds holding CMRA

LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BCM
Bluefin Capital Management New York $156M AUM 18.47% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jump Financial's CMRA Position: Q3 2022 in Review

Jump Financial sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q3 2022, closing a stake of 21,922 shares — an estimated $58K sold.

Jump Financial first reported a position in CMRA in Q2 2022 and held it in 1 quarter. The position peaked at $58K in Q2 2022. 16 funds tracked by Wall St. Rank hold CMRA as of Q3 2022.

  • Jump Financial reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Jump Financial sold 21,922 Comera Life Sciences Holdings, Inc. Common Stock shares in Q3 2022, an estimated $58K.
  • Jump Financial first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Jump Financial's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $58K in Q2 2022.
  • 16 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q3 2022.

Based on Jump Financial's 13F filing for Q3 2022, filed 7 Nov 2022.